NCT05887700View on ClinicalTrials.gov

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

RecruitingOBSERVATIONAL
Enrollment

145

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Atrial Septal Defect
Interventions
DEVICE

CeraFlex™ Atrial Septal Defect (ASD) Closure System

The CeraFlex™ ASD Occluder have two types of occluders, CeraFlex™ ASD Occluder and CeraFlex™ Multi-fenestrated (Cribriform) ASD Occluder. The CeraFlex™ ASD Occluder is percutaneous, transcatheter closure devices for the non-surgical closure of atrial septal defects.

Trial Locations (7)

Unknown

NOT_YET_RECRUITING

Hospital Pequeno Príncipe, Curitiba

NOT_YET_RECRUITING

Universidade Federal do Ceará, Fortaleza

NOT_YET_RECRUITING

Santa Casa de Misericórdia de Porto Alegre, Porto Alegre

NOT_YET_RECRUITING

HCOR - Associação Beneficente Síria, São Paulo

NOT_YET_RECRUITING

Hospital Beneficência Portuguesa, São Paulo

RECRUITING

Onassis Cardiac Surgery Center, Kallithea

RECRUITING

IRCCS Policlinico San Donato, Milan

All Listed Sponsors
lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY